Q4KMQ2 (ANO6_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 76.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Anoctamin-6 Alternative name(s): Small-conductance calcium-activated nonselective cation channel Short name=SCAN channel Transmembrane protein 16F | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 910 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Small-conductance calcium-activated nonselective cation (SCAN) channel which acts as a regulator of phospholipid scrambling in platelets and osteoblasts. Phospholipid scrambling results in surface exposure of phosphatidylserine which in platelets is essential to trigger the clotting system whereas in osteoblasts is essential for the deposition of hydroxyapatite during bone mineralization. Can generate outwardly rectifying chloride channel currents in airway epithelial cells and Jurkat T lymphocytes. Ref.6 Ref.7 Ref.10 Ref.14 Ref.15 |
| Enzyme regulation | Exhibits synergistic gating by Ca2+ and voltage. Inhibited by some non-specific cation channel blockers such as: ruthenium red, 2-aminoethyl diphenylborinate (2APB), gadolinium and cadmium ions By similarity. |
| Subcellular location | Cell membrane; Multi-pass membrane protein. Note: Shows an intracellular localization according to Ref.11. Ref.6 Ref.7 Ref.11 Ref.15 |
| Tissue specificity | Expressed in embryonic stem cell, fetal liver, retina, chronic myologenous leukemia and intestinal cancer. Ref.4 |
| Involvement in disease | Scott syndrome (SCTS) [MIM:262890]: A mild bleeding disorder due to impaired surface exposure of procoagulant phosphatidylserine (PS) on platelets and other blood cells, following activation with Ca(2+)-elevating agents. |
| Miscellaneous | The term 'anoctamin' was coined because these channels are anion selective and have eight (OCT) transmembrane segments. There is some dissatisfaction in the field with the Ano nomenclature because it is not certain that all the members of this family are anion channels or have the 8-transmembrane topology. |
| Sequence similarities | Belongs to the anoctamin family. |
Ontologies
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q4KMQ2-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q4KMQ2-2) The sequence of this isoform differs from the canonical sequence as follows: 23-23: I → IGDVPASRRPFLTPHTHLPSSL | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 910 | 910 | Anoctamin-6 | PRO_0000191757 | |||||
Regions | |||||||||
| Topological domain | 1 – 294 | 294 | Cytoplasmic Potential | ||||||
| Transmembrane | 295 – 315 | 21 | Helical; Potential | ||||||
| Topological domain | 316 – 375 | 60 | Extracellular Potential | ||||||
| Transmembrane | 376 – 396 | 21 | Helical; Potential | ||||||
| Topological domain | 397 – 454 | 58 | Cytoplasmic Potential | ||||||
| Transmembrane | 455 – 475 | 21 | Helical; Potential | ||||||
| Topological domain | 476 – 513 | 38 | Extracellular Potential | ||||||
| Transmembrane | 514 – 534 | 21 | Helical; Potential | ||||||
| Topological domain | 535 – 551 | 17 | Cytoplasmic Potential | ||||||
| Transmembrane | 552 – 572 | 21 | Helical; Potential | ||||||
| Topological domain | 573 – 669 | 97 | Extracellular Potential | ||||||
| Transmembrane | 670 – 690 | 21 | Helical; Potential | ||||||
| Topological domain | 691 – 725 | 35 | Cytoplasmic Potential | ||||||
| Transmembrane | 726 – 746 | 21 | Helical; Potential | ||||||
| Topological domain | 747 – 824 | 78 | Extracellular Potential | ||||||
| Transmembrane | 825 – 845 | 21 | Helical; Potential | ||||||
| Topological domain | 846 – 910 | 65 | Cytoplasmic Potential | ||||||
Amino acid modifications | |||||||||
| Glycosylation | 329 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 361 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 493 | 1 | N-linked (GlcNAc...) Ref.5 | ||||||
| Glycosylation | 777 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 790 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 802 | 1 | N-linked (GlcNAc...) Potential | ||||||
Natural variations | |||||||||
| Alternative sequence | 23 | 1 | I → IGDVPASRRPFLTPHTHLPS SL in isoform 2. | VSP_042893 | |||||
| Natural variant | 128 | 1 | A → T. Corresponds to variant rs2162321 [ dbSNP | Ensembl ]. | VAR_028109 | |||||
Experimental info | |||||||||
| Sequence conflict | 837 | 1 | F → L in AAH98410. Ref.2 | ||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "The finished DNA sequence of human chromosome 12." Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R. Gibbs R.A.Nature 440:346-351(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [2] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2). Tissue: Placenta and Testis. |
| [3] | "The full-ORF clone resource of the German cDNA consortium." Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., Wiemann S., Schupp I. BMC Genomics 8:399-399(2007) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 772-910 (ISOFORM 1/2). Tissue: Adipose tissue. |
| [4] | "Identification and characterization of TMEM16E and TMEM16F genes in silico." Katoh M., Katoh M. Int. J. Oncol. 24:1345-1349(2004) [PubMed] [Europe PMC] [Abstract] Cited for: TISSUE SPECIFICITY. |
| [5] | "Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry." Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H. J. Proteome Res. 8:651-661(2009) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-493, MASS SPECTROMETRY. Tissue: Liver. |
| [6] | "Expression and function of epithelial anoctamins." Schreiber R., Uliyakina I., Kongsuphol P., Warth R., Mirza M., Martins J.R., Kunzelmann K. J. Biol. Chem. 285:7838-7845(2010) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION. |
| [7] | "Calcium-dependent phospholipid scrambling by TMEM16F." Suzuki J., Umeda M., Sims P.J., Nagata S. Nature 468:834-838(2010) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION, INVOLVEMENT IN SCOTT SYNDROME. |
| [8] | "Physiological roles and diseases of Tmem16/Anoctamin proteins: are they all chloride channels?" Duran C., Hartzell H.C. Acta Pharmacol. Sin. 32:685-692(2011) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW. |
| [9] | "Anoctamins." Kunzelmann K., Tian Y., Martins J.R., Faria D., Kongsuphol P., Ousingsawat J., Thevenod F., Roussa E., Rock J., Schreiber R. Pflugers Arch. 462:195-208(2011) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW. |
| [10] | "Anoctamin 6 is an essential component of the outwardly rectifying chloride channel." Martins J.R., Faria D., Kongsuphol P., Reisch B., Schreiber R., Kunzelmann K. Proc. Natl. Acad. Sci. U.S.A. 108:18168-18172(2011) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [11] | "ANOs 3-7 in the anoctamin/Tmem16 Cl- channel family are intracellular proteins." Duran C., Qu Z., Osunkoya A.O., Cui Y., Hartzell H.C. Am. J. Physiol. 302:C482-C493(2012) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION. |
| [12] | "The anoctamin (TMEM16) gene family: calcium-activated chloride channels come of age." Winpenny J.P., Gray M.A. Exp. Physiol. 97:175-176(2012) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW. |
| [13] | "The anoctamin family: TMEM16A and TMEM16B as calcium-activated chloride channels." Scudieri P., Sondo E., Ferrera L., Galietta L.J. Exp. Physiol. 97:177-183(2012) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW, ABSENCE OF CALCIUM-ACTIVATED CHLORIDE CHANNEL ACTIVITY. |
| [14] | "Expression and function of epithelial anoctamins." Kunzelmann K., Schreiber R., Kmit A., Jantarajit W., Martins J.R., Faria D., Kongsuphol P., Ousingsawat J., Tian Y. Exp. Physiol. 97:184-192(2012) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW, FUNCTION. |
| [15] | "Anoctamins are a family of Ca2+ activated Cl- channels." Tian Y., Schreiber R., Kunzelmann K. J. Cell Sci. 125:4991-4998(2012) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AC009248 Genomic DNA. No translation available. AC009778 Genomic DNA. No translation available. AC063924 Genomic DNA. No translation available. BC098410 mRNA. Translation: AAH98410.1. BC136445 mRNA. Translation: AAI36446.1. AL833405 mRNA. Translation: CAD38638.1. |
| IPI | IPI00151710. IPI00790445. |
| RefSeq | NP_001020527.2. NM_001025356.2. NP_001136150.1. NM_001142678.1. NP_001136151.1. NM_001142679.1. NP_001191732.1. NM_001204803.1. |
| UniGene | Hs.505339. |
3D structure databases | |
| ProteinModelPortal | Q4KMQ2. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q4KMQ2. 1 interaction. |
| STRING | 9606.ENSP00000391417. |
PTM databases | |
| PhosphoSite | Q4KMQ2. |
Polymorphism databases | |
| DMDM | 116242820. |
Proteomic databases | |
| PaxDb | Q4KMQ2. |
| PRIDE | Q4KMQ2. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000320560; ENSP00000320087; ENSG00000177119. ENST00000423947; ENSP00000409126; ENSG00000177119. |
| GeneID | 196527. |
| KEGG | hsa:196527. |
| UCSC | uc001roo.3. human. |
Organism-specific databases | |
| CTD | 196527. |
| GeneCards | GC12P045609. |
| H-InvDB | HIX0010565. |
| HGNC | HGNC:25240. ANO6. |
| HPA | HPA038958. |
| MIM | 262890. phenotype. 608663. gene. |
| neXtProt | NX_Q4KMQ2. |
| Orphanet | 806. Scott syndrome. |
| PharmGKB | PA164715690. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG320103. |
| HOGENOM | HOG000006509. |
| HOVERGEN | HBG069519. |
| InParanoid | Q4KMQ2. |
| OMA | GVWVTLF. |
Gene expression databases | |
| ArrayExpress | Q4KMQ2. |
| Bgee | Q4KMQ2. |
| CleanEx | HS_ANO6. |
| Genevestigator | Q4KMQ2. |
Family and domain databases | |
| InterPro | IPR007632. Anoctamin. [Graphical view] |
| PANTHER | PTHR12308. PTHR12308. 1 hit. |
| Pfam | PF04547. Anoctamin. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| ChiTaRS | ANO6. human. |
| GenomeRNAi | 196527. |
| NextBio | 89521. |
| SOURCE | Search... |
Entry information
| Entry name | ANO6_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q4KMQ2 Secondary accession number(s): A6NNM6 Q8N3Q2 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 12 Human chromosome 12: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
